Article

Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text
Advertising


Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates



Journal of the American Academy of Dermatology
Volume 52, n° 3S
page P17 (mars 2005)
Doi : 10.1016/j.jaad.2004.10.080
Efficacy and safety of a new salicylic acid derivative (LHA) alone or as a complement of tretinoin in acne treatment
 

Alain Richard, PhD, La Roche-Posay Pharmaceutical Laboratories, Asnieres, France; Fu Wen Wen, MD, Li Ming, MD, Liu Jian Hang, MD, Shanghai Hospital, Shanghai, China


 P126
Dr. Richard is Clinical Studies Director of La Roche-Posay Pharmaceutical Laboratories.
Supported by La Roche-Posay Pharmaceutical Laboratories


Top of the page

© 2005  American Academy of Dermatology, Inc.@@#104156@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline
You can move this window by clicking on the headline
@@#110903@@